IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 178 filers reported holding IMPAX LABORATORIES INC in Q4 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $8,863,000 | -15.9% | 276,784 | +23.1% | 0.93% | +9.3% |
| Q1 2015 | $10,534,000 | +20.4% | 224,754 | -18.6% | 0.85% | +11.7% |
| Q4 2014 | $8,749,000 | -52.3% | 276,169 | -64.3% | 0.76% | -38.0% |
| Q3 2014 | $18,354,000 | -12.0% | 774,092 | +11.4% | 1.23% | -9.5% |
| Q2 2014 | $20,846,000 | – | 695,100 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
| Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
| BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
| Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
| Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
| Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
| Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
| Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |